Insider Transactions in Q2 2024 at Age X Therapeutics, Inc. (AGE)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2024
|
Steven Mintz Director |
BUY
Open market or private purchase
|
Direct |
2,600
+19.25%
|
$23,400
$9.0 P/Share
|
|
Jun 21
2024
|
Steven Mintz Director |
BUY
Open market or private purchase
|
Direct |
5,000
+37.57%
|
$45,000
$9.5 P/Share
|
|
May 30
2024
|
Gregory Bailey Director |
BUY
Open market or private purchase
|
Direct |
5,205
+20.48%
|
$46,845
$9.5 P/Share
|
|
May 29
2024
|
Gregory Bailey Director |
BUY
Open market or private purchase
|
Direct |
1,173
+7.25%
|
$10,557
$9.5 P/Share
|
|
May 28
2024
|
Gregory Bailey Director |
BUY
Open market or private purchase
|
Direct |
9,019
+39.48%
|
$81,171
$9.5 P/Share
|
|
May 23
2024
|
Gregory Bailey Director |
BUY
Open market or private purchase
|
Direct |
2,371
+33.02%
|
$21,339
$9.5 P/Share
|
|
May 21
2024
|
Gregory Bailey Director |
BUY
Open market or private purchase
|
Direct |
2,338
+37.81%
|
$21,042
$9.5 P/Share
|
|
May 21
2024
|
Steven Mintz Director |
BUY
Open market or private purchase
|
Indirect |
9,151
+33.75%
|
$82,359
$9.88 P/Share
|
|
May 20
2024
|
Steven Mintz Director |
BUY
Open market or private purchase
|
Indirect |
2,675
+40.22%
|
$24,075
$9.45 P/Share
|
|
May 20
2024
|
Gregory Bailey Director |
BUY
Open market or private purchase
|
Direct |
100
+50.0%
|
$900
$9.0 P/Share
|
|
May 17
2024
|
Steven Mintz Director |
BUY
Open market or private purchase
|
Indirect |
554
+50.0%
|
$4,432
$8.5 P/Share
|